Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.12 | 0.7 |
mRNA | AZD8055 | GDSC1000 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.7 |
mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.7 |
mRNA | AZD1480 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.7 |
mRNA | CEP-701 | FIMM | pan-cancer | AAC | 0.054 | 0.7 |
mRNA | foretinib | GDSC1000 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | SJ-172550 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.7 |
mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |